EPIX
Essa Pharma Inc
Halal Rating :
Last Price
$1.75
Last updated:
Market Cap
-
7D Change
1.16%
1 Year Change
-79.44%
Company Overview
Industries
Exchange
Next Earnings Date
ESSA Pharma Inc. is a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer. Their lead product candidate, EPI-7386, is a potential treatment for patients with metastatic castration-resistant prostate cancer. The company is in the development phase and currently generates no revenue as it continues its research and clinical trials.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Essa Pharma Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.